Recurrent Neurofibromatosis Type 1
specificThe reemergence of neurofibromatosis type 1 after a period of remission.
4
Centers
4
Active Trials
—
Cancer Funding
Top Centers for Recurrent Neurofibromatosis Type 1(4)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 62.5 |
| 2 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 62.5 |
| 3 | University of Illinois Cancer CenterChicago, IL Active Research Program | 62.5 |
| 4 | University of Cincinnati Cancer CenterCincinnati, OH Active Research Program | 62.5 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →